Add Yahoo as a preferred source to see more of our stories on Google. In 1910, Professor Ernst Fuchs, an Austrian ophthalmologist, published an article describing 13 patients with Fuchs’ dystrophy, a ...
Design Therapeutics is set to present significant safety findings from its Phase 1 trial of DT-168, highlighting progress in their clinical development for treating Fuchs endothelial corneal dystrophy ...
The MarketWatch News Department was not involved in the creation of this content. The rising incidence of corneal diseases such as keratoconus, Fuchs' dystrophy, and corneal scarring from infections ...
Québec City, April 14, 2023 - Fuchs' endothelial corneal dystrophy, a degenerative eye disease, causes progressive vision loss that can induce blindness. It is the leading cause of corneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results